Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.42 +0.03 (+8.98%)
As of: Oct 21, 2026 · 3:59 PM EDT

Biodexa Pharmaceuticals (BDRX) Other Operating Expenses (2013 - 2026)

Updated

Biodexa Pharmaceuticals (BDRX) reported Other Operating Expenses of $7,966 for the quarter ended Dec 31, 2017, down 19.9% from $9,946 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Other Operating Expenses (2013 - 2026) Analysis & Trends

For the year ended Dec 31, 2017, Biodexa Pharmaceuticals posted Other Operating Expenses of $7,729, down 28.8% from the prior year.

  • By year, Other Operating Expenses came in at $10,853 in the year ended Dec 31, 2016 (+1.4%) and $10,704 in the year ended Dec 31, 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Biodexa Pharmaceuticals 4,123.69 -23.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.33 Mn
Dec 31, 2025 -3.16 Mn
Jun 30, 2025 -3.17 Mn
Dec 31, 2024 -2.61 Mn
Jun 30, 2023 -2.87 Mn
Dec 31, 2022 -2.17 Mn
Dec 31, 2020 -6.54 Mn
Dec 31, 2019 -4.94 Mn
Dec 31, 2018 -5.65 Mn
Dec 31, 2017 -1.16 Mn
Dec 31, 2016 -6.17 Mn
Dec 31, 2015 -13.99 Mn
Dec 31, 2014 -6.98 Mn
Dec 31, 2013 -4.41 Mn
API Access

Biodexa Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BDRX&period=max&api_key=YOUR_API_KEY